| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000044248 |
| Receipt No. | R000050297 |
| Scientific Title | Development of new sanitary products |
| Date of disclosure of the study information | 2021/06/01 |
| Last modified on | 2021/05/18 (Ver. 1) |
| Basic information | ||
| Public title | Development of new sanitary products based on the survey of gynecologic patients | |
| Acronym | Development of new sanitary products | |
| Scientific Title | Development of new sanitary products | |
| Scientific Title:Acronym | Development of new sanitary products | |
| Region |
|
|
| Condition | ||
| Condition | vulvovaginal diseases | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Analyze the presence or absence of vulvovaginal diseases and the relationship between vulvovaginal conditions and the symptoms and feelings of the individual, and develop hygiene products that can be alleviated according to vulvovaginal diseases and other conditions.
|
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Step 1
Vulvovaginal conditions, symptoms, and how to deal with them, etc. Step 2 Change in vulvovaginal conditions before and after using the test sample, etc. |
| Key secondary outcomes | Step 1
Association of doctors' diagnosis and patients' feelings, and causal relationship with coping methods, etc. Step 2 Association of doctors' diagnosis and patients' feelings, etc. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Testing the use of sanitary products | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | A regular visit to a gynecologist
Patients presenting with a chief complaint of vulvar symptoms Women over 20 years old Consent has been obtained based on informed consent. |
|||
| Key exclusion criteria | Not applicable | |||
| Target sample size | 120 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, Osaka University | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 565-0871 | ||||||
| Address | 2-2 Yamadaoka Suitashi, Osaka | ||||||
| TEL | 06-6879-3351 | ||||||
| y.ueda@gyne.med.osaka-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, Osaka University | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 565-0871 | ||||||
| Address | 2-2 Yamadaoka Suitashi, Osaka | ||||||
| TEL | 06-6879-3351 | ||||||
| Homepage URL | |||||||
| y.ueda@gyne.med.osaka-u.ac.jp | |||||||
| Sponsor | |
| Institute | Osaka University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Unicharm |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka University Clinical Research Review Committee |
| Address | 2-2 Yamadaoka Suitashi, Osaka |
| Tel | 06-6210-8296 |
| rinri@hp-crc.med.osaka-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050297 |